Literature DB >> 19214296

Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.

Robert Breton1, Jean Mathieu.   

Abstract

BACKGROUND: Myotonic dystrophy type 1 (DM1) has been associated with an increased risk of sudden death, either by heart block or malignant ventricular arrhythmias. Identifying patients at risk remains difficult and no consensus has been reached regarding the best approach for follow-up and prevention of sudden death.
OBJECTIVES: To identify noninvasive clinical and electrocardiographic predictors of adverse cardiac events in patients with DM1.
METHODS: Clinical and serial electrocardiographic data on 428 patients with a DNA-proven diagnosis of DM1, followed during a mean period of 11.7 years, were reviewed. Variables associated with adverse cardiac events were identified.
RESULTS: Eleven patients (2.6%) experienced sudden death and 13 (3.0%) required implantation of a pacemaker. On univariate analysis, adverse events were associated with advancing age, prolongation of the PR, QRS and corrected QT (QTc) intervals, as well as the degree of neuromuscular impairment. No such relationship was found with the extent of genetic anomaly (number of cytosine-thymine-guanine repeats). However, multivariate analysis using Cox proportional hazards models showed that only baseline PR and QTc intervals were significantly linked to the end points of sudden death or pacemaker implantation; the age-adjusted RR was 3.7 (95% CI 1.5 to 8.6) if baseline PR was 200 ms or longer (P=0.003), and 3.0 (95% CI 1.0 to 8.8) if the baseline QTc was 450 ms or longer (P=0.047).
CONCLUSIONS: In a large unselected cohort of 428 patients with DM1, the cumulative incidence of sudden death was relatively low, and the delayed conduction on surface electrocardiogram was found to be potentially helpful for identifying patients at risk for sudden death or pacemaker implantation.

Entities:  

Mesh:

Year:  2009        PMID: 19214296      PMCID: PMC2691914          DOI: 10.1016/s0828-282x(09)70479-9

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  40 in total

Review 1.  Myotonic dystrophy and the heart.

Authors:  G Pelargonio; A Dello Russo; T Sanna; G De Martino; F Bellocci
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

2.  Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions.

Authors:  M-E Arsenault; C Prévost; A Lescault; C Laberge; J Puymirat; J Mathieu
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

3.  Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?

Authors:  N R Clarke; A D Kelion; J Nixon; D Hilton-Jones; J C Forfar
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

4.  Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy.

Authors:  A Lazarus; J Varin; Z Ounnoughene; H Radvanyi; C Junien; J Coste; P Laforet; B Eymard; H M Becane; S Weber; D Duboc
Journal:  Circulation       Date:  1999-03-02       Impact factor: 29.690

5.  Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy.

Authors:  J Mathieu; H Boivin; D Meunier; M Gaudreault; P Bégin
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

6.  Sibship stability of genotype and phenotype in myotonic dystrophy.

Authors:  D Brisson; M Tremblay; C Prévost; C Laberge; J Puymirat; J Mathieu
Journal:  Clin Genet       Date:  2002-09       Impact factor: 4.438

7.  Quantitative motor assessment in myotonic dystrophy.

Authors:  J Mathieu; H Boivin; C L Richards
Journal:  Can J Neurol Sci       Date:  2003-05       Impact factor: 2.104

8.  Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I.

Authors:  Deepak Bhakta; Miriam R Lowe; William J Groh
Journal:  Am Heart J       Date:  2004-02       Impact factor: 4.749

9.  Cardiac involvement and CTG expansion in myotonic dystrophy.

Authors:  Karen Merlevede; Dimitri Vermander; Paul Theys; Eric Legius; Hugo Ector; Wim Robberecht
Journal:  J Neurol       Date:  2002-06       Impact factor: 4.849

10.  Clinical and induced ventricular tachycardia in a patient with myotonic dystrophy.

Authors:  D S Cannom; M G Wyman; B N Goldreyer
Journal:  J Am Coll Cardiol       Date:  1984-09       Impact factor: 24.094

View more
  10 in total

1.  A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre.

Authors:  Elisabetta Bucci; Marco Testa; Loretta Licchelli; Alessandra Frattari; Nadia Attalla El Halabieh; Erica Gabriele; Giulia Pignatelli; Tiziana De Santis; Laura Fionda; Fiammetta Vanoli; Stefania Morino; Matteo Garibaldi; Antonella Di Pasquale; Nicola Vanacore; Annalisa Botta; Giovanni Antonini
Journal:  J Neurol       Date:  2018-02-10       Impact factor: 4.849

2.  Cardiac autonomic function in type 1 and type 2 myotonic dystrophy.

Authors:  Piotr Bienias; Anna Łusakowska; Michał Ciurzyński; Zuzanna Rymarczyk; Katarzyna Irzyk; Michał Konwerski; Kamil Ciąpała; Paweł Kowalski; Anna Kamińska; Piotr Pruszczyk
Journal:  Clin Auton Res       Date:  2017-03-20       Impact factor: 4.435

3.  Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy.

Authors:  Saman Nazarian; Kathryn R Wagner; Brian S Caffo; Gordon F Tomaselli
Journal:  Pacing Clin Electrophysiol       Date:  2010-10-14       Impact factor: 1.976

4.  Severe dilated cardiomyopathy in a patient with myotonic dystrophy type 2 and homozygous repeat expansion in ZNF9.

Authors:  Teresa M Lee; Mathew S Maurer; Izabela Karbassi; Corey Braastad; Sat D Batish; Wendy K Chung
Journal:  Congest Heart Fail       Date:  2011-11-03

5.  The evolution of infrahissian conduction time in myotonic dystrophy patients: clinical implications.

Authors:  Bénédicte Lallemand; Nicolas Clementy; Anne Bernard-Brunet; Bertrand Pierre; Philippe Corcia; Laurent Fauchier; Martine Raynaud; Sybille Pellieux; Dominique Babuty
Journal:  Heart       Date:  2011-10-29       Impact factor: 5.994

6.  Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction.

Authors:  Mouli Chakraborty; Estela Selma-Soriano; Emile Magny; Juan Pablo Couso; Manuel Pérez-Alonso; Nicolas Charlet-Berguerand; Ruben Artero; Beatriz Llamusi
Journal:  Dis Model Mech       Date:  2015-10-29       Impact factor: 5.758

7.  Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes.

Authors:  Estefania Cerro-Herreros; Mouli Chakraborty; Manuel Pérez-Alonso; Rubén Artero; Beatriz Llamusí
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

8.  Cardiac Involvement and Arrhythmias Associated with Myotonic Dystrophy.

Authors:  Daniel McBride; Amrish Deshmukh; Supriya Shore; Melissa A Elafros; Jackson J Liang
Journal:  Rev Cardiovasc Med       Date:  2022-04-02       Impact factor: 4.430

9.  Prolonged Corrected QT Interval in Patients with Myotonic Dystrophy Type 1.

Authors:  Kang Min Park; Kyong Jin Shin; Sung Eun Kim; Jinse Park; Sam Yeol Ha; Byoung Joon Kim
Journal:  J Clin Neurol       Date:  2013-07-01       Impact factor: 3.077

10.  Symptomatic Trifascicular Block in Steinert's Disease: Is It Too Soon for a Pacemaker?

Authors:  Glenmore Lasam; Roberto Roberti; Gina LaCapra; Roberto Ramirez
Journal:  Case Rep Cardiol       Date:  2016-02-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.